ReviewFrontiers in immunology2025

Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes.

Hui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.